Stock Scorer

AstraZeneca PLC (AZN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 5B 10B 15B Q3 '17: 4.9B Q4 '17: 5.5B Q1 '18: 5B Q2 '18: 5.2B Q3 '18: 5.3B Q4 '18: 5.8B Q1 '19: 5.5B Q2 '19: 5.8B Q3 '19: 6.1B Q4 '19: 6.2B Q1 '20: 6.3B Q2 '20: 6.3B Q3 '20: 6.5B Q4 '20: 7B Q1 '21: 7.3B Q2 '21: 8.2B Q2 '22: 10.8B Q2 '23: 11.4B Q2 '24: 12.9B Q2 '25: 14.5B Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20 Q2 '22 Q2 '25

Gross Profit Quarterly

0 5B 10B 15B Q2 '17: 4.1B Q2 '18: 4.1B Q2 '19: 4.8B Q2 '20: 5.3B Q2 '21: 6B Q2 '22: 7.8B Q2 '23: 9.5B Q2 '24: 10.8B Q2 '25: 12B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Operating Income Quarterly

0 1.5B 3B 4.5B Q2 '17: 925M Q2 '18: 763M Q2 '19: 493M Q2 '20: 1.3B Q2 '21: 1.1B Q2 '22: 539M Q2 '23: 2.5B Q2 '24: 2.7B Q2 '25: 3.5B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Net Income Quarterly

0 900M 1.8B 2.7B Q2 '17: 446M Q2 '18: 319M Q2 '19: 107M Q2 '20: 738M Q2 '21: 550M Q2 '22: 360M Q2 '23: 1.8B Q2 '24: 1.9B Q2 '25: 2.4B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Cost of Revenue Quarterly

0 1.5B 3B 4.5B Q2 '17: 950M Q2 '18: 1B Q2 '19: 1.1B Q2 '20: 984M Q2 '21: 2.2B Q2 '22: 3B Q2 '23: 2B Q2 '24: 2.2B Q2 '25: 2.5B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Shares Outstanding Quarterly

0 600M 1.2B 1.8B Q2 '17: 1.3B Q2 '18: 1.3B Q2 '19: 1.3B Q2 '20: 1.3B Q2 '21: 1.3B Q2 '22: 1.6B Q2 '23: 1.6B Q2 '24: 1.6B Q2 '25: 1.6B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS Annual

0.00 2.50 5.00 7.50 FY21: 0.08 FY22: 2.11 FY23: 3.81 FY24: 4.50 FY25: 6.54 FY21 FY22 FY23 FY24 FY25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for AZN: Operating Cash Flow, Free Cash Flow. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.